Coronavirus outbreak underscores potential health risks in China’s wild animal trade
China implemented controls on wildlife markets after the SARS epidemic, but those controls soon evaporated. The country remains a major consumer of wild and endangered animals for meat, as well as in traditional medicine.
Yuen Kwok-yung at the University of Hong Kong-Shenzhen Hospital, one of the authors of a new study on coronavirus and a leading authority on SARS, said the wild animal or game meat trade had obviously been rekindled since the SARS outbreak ended in 2003. The SARS outbreak claimed more than 750 lives in China and other countries.
“This is understandable that change of food or eating culture is always a difficult issue,” he wrote in an email. “But the lesson of this major epidemic is that the life, ecosystem and habitat of wild life must be respected.”
Viruses from wildlife can easily mutate and jump from animals to humans, and then from humans to humans, he said.
“The price of such an epidemic is staggering, and this should not be allowed to happen again.”
Struggling to contain the outbreak, the Chinese government has imposed travel bans on 15 cities in the central Hubei province — effectively placing 48 million people on lockdown — and granted itself wide-ranging emergency powers across the country to enforce blockades, requisition housing and transport, and close businesses and schools.
China has been praised for reacting more swiftly and more transparently to this latest outbreak than with SARS in 2002, when it was widely accused of initially trying to cover up the epidemic.
A study published in the Lancet medical journal Friday confirmed the current outbreak is a new form of coronavirus, which is closest to the SARS-related coronaviruses found in Chinese horseshoe bats.
Some scientists say they believe another species was involved in transmitting the disease to humans, but no consensus has yet emerged on which animal, with theories ranging from snakes to mink.
“Wild animal markets are a petri dish for an epidemic and an unacceptable risk that should be consigned to history as soon as possible,” said Peter Knights of WildAid, a San Francisco-based group that works to end wildlife trade.
“Stress, dehydration, malnourishment, filthy conditions, mixing of species, wild and domestic, are the perfect cocktail to create a new deadly disease, and basing them in urban centers ensures a quick and wide dispersal to a wider world,” he said.
The trade represents a massive risk to human health and economies in parts of Asia as well as in Africa, he said.
“After SARS and now this, China urgently needs a strictly enforced ban on these markets and a massive awareness campaign to reduce demand for bushmeat,” he said.
China has shown it is capable of regulating the illegal wildlife trade when it wants to, banning the ivory trade at the end of 2017 and enforcing a customs crackdown on ivory smuggling.
But a strong lobby within the government, led by the State Forestry Administration, sees wild animals not as something to be protected but generally as a resource that can be utilized.
The Wuhan city government closed the seafood market at the beginning of January after the first cases of coronavirus emerged in people working there.
On the Weibo social media platform, a user posted that the market sold live cats, dogs, wild chickens, snakes and marmots. “There was even a signboard saying that they have live monkeys and deer for sale,” the post said, according to China Daily.
This provides “ideal conditions for the emergence of new viruses that threaten human health, economic stability, and ecosystem health,” Christian Walzer, executive director of health for the Wildlife Conservation Society, said in a statement. “The re-assortment and exchange of viral components between species at live animal markets is seen as the major source of new viruses.”
Walzer cited avian influenza, swine influenza, SARS and MERS, or Middle East respiratory syndrome, as examples of diseases originating in animals and subsequently transmitted between humans, “creating the conditions for a rapid global pandemic spread.”
CORRECTION: An error during the editing process meant that an earlier version of this article stated the SARS crisis was eight years ago, the article has been corrected to show that it was 17 years ago.
Equine Pharmaceuticals and Supplements Market Analysis By Top Players – Merck Animal Health, Bayer Animal Health, Elanco Animal Health
Jan 28, 2020 (Market Insight Reports via COMTEX) -- The Equine Pharmaceuticals and Supplements Market Research Report Forecast 2020-2025 is a valuable source of insightful data for business strategists. This Equine Pharmaceuticals and Supplements Market study provides comprehensive data on aspects of competitive intelligence, market research, strategy, planning, pricing and forecasting that enhances the understanding, scope, and application of this report.
The major key players covered in this report: Boehringer Ingelheim, Kyoritsu Seiyaku, Merck Animal Health, Bayer Animal Health, Elanco Animal Health, Zoetis, Virbac, Dechra Veterinary Products, Norbrook Equine, CEVA, Vetoquinol, Ouro Fino Saude, Audevard, Protexin Healthcare.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
Click Here to Get Free Sample PDF Copy of Latest Research on Equine Pharmaceuticals and Supplements Market 2019:https://www.marketinsightsreports.com/reports/01201783226/global-equine-pharmaceuticals-and-supplements-market-growth-2020-2025/inquiry?source=MW&mode=86
In the last several years, the global market of Equine Pharmaceuticals and Supplements developed rapidly, with an average growth rate of 4.52% from 2013 to 2017. In 2017, global revenue of Equine Pharmaceuticals and Supplements is nearly 977 M USD; the actual production is about 13700 K Unit. The global average price of Equine Pharmaceuticals and Supplements is in the increasing trend, from 71.0 USD/Unit in 2013 to 71.3 USD/Unit in 2017. With the situation of the global economy, prices will be in increasing trend in the following five years. The classification of Equine Pharmaceuticals and Supplements includes Pharmaceuticals and Supplements, and the proportion of Pharmaceuticals in 2017 is about 79%.With the presence of 10 million horses and as one of the horse exporting nations in the world, the USA drives the North American equine pharmaceuticals and supplements market. Some of the key players in the global Equine Pharmaceuticals and Supplements market are AFFYMETRIX, Bayer Animal Health, Boehringer Ingelheim, Celltrion Inc, Elanco Animal Health, Merck Animal Health, and Merial
This report segments the global Equine Pharmaceuticals and Supplements Market based on Types are:Pharmaceuticals, Supplements.
Based on Application, the Global Equine Pharmaceuticals and Supplements Market is Segmented into:Thoroughbred Horse, Other Types of Horses.
Inquire for Discount:https://www.marketinsightsreports.com/reports/01201783226/global-equine-pharmaceuticals-and-supplements-market-growth-2020-2025/discount?source=MW&mode=86
Regions covered By Equine Pharmaceuticals and Supplements Market Report.North America: United States, Canada, and Mexico.
Central and South America: Brazil and Argentina.
The Middle East and Africa: Saudi Arabia, and Turkey.
Europe: Germany, France, UK, Italy, Spain, and Russia.
Asia-Pacific: China, India, Japan, South Korea, Australia, Indonesia, and Singapore.
These segments are thoroughly evaluated on an individual basis and a team of analysts has ensured to give a crystal clear idea about various lucrative segments of the industry. This detailed analysis of segmentation help in offering precise results about the markets related to the industry.
- Detailed overview of Equine Pharmaceuticals and Supplements Market- Changing Equine Pharmaceuticals and Supplements market dynamics of the industry- In-depth market segmentation by Type, Application, etc.- Historical, current and projected Equine Pharmaceuticals and Supplements market size in terms of volume and value- Recent industry trends and developments- Competitive landscape of Equine Pharmaceuticals and Supplements Market- Strategies of key players and product offerings- Potential and niche segments/regions exhibiting promising growth.
The report has 150 tables and figures browse the report description and TOC:https://www.marketinsightsreports.com/reports/01201783226/global-equine-pharmaceuticals-and-supplements-market-growth-2020-2025?source=MW&mode=86ABOUT US:
MarketInsightsReports is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. MarketInsightsReports offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Irfan Tamboli (Sales Manager) – Market Insights ReportsPhone: + 1704 266 3234 | +91-750-707-8687sales@marketinsightsreports.com | irfan@marketinsightsreports.com
COMTEX_361163503/2599/2020-01-28T11:19:33
Animal Stem Cell Therapy Market: Growth Opportunities to Tap into in 2020| QYR Consulting
Key Players
Prominent Companies are Keen to Engage in Strategic Collaborations
Some of the key players operating in the worldwide Animal Stem Cell industry are VETSTEM BIOPHARMA, Medivet Biologics LLC, J-ARM, VetCell Therapeutics, Magellan Stem Cells, Celvet Inc., Animal Cell Therapies, Animacel, Cell Therapy Sciences, Animal Stem Care, and Kintaro Cells Power. The market players are involved in strategic collaborations to improve their market position.
For instance, in 2017 VetCell Therapeutics announced a collaborative partnership with Western University of Health Sciences to study treatment of canine atopic dermatitis with stem cells.
Have Queries? To request a sample report template or speak to an expert click here: https://www.qyrconsulting.com/request-sample/7937
Market Dynamics
Quality Treatment in Veterinary Care is Expected to Foster the Market Growth
Increasing demand for quality treatment of animals for injury with the help of therapy of transferring stem cells is expected to play a major role in the growth of the market. Increasing prevalence of diseases and disorders in animals and a growing emphasis on providing treatment without side-effects is contributing to the growth of the market. Recent developments in stem cell therapy have enabled treatment of other animals besides dogs, cats, and horses, which is facilitating the protection of animals. This is likely to boost the growth of the Animal Stem Cell Therapy industry over the next few years.
Segmental Analysis
Increasing Demand for Treatment of Animals is Likely to Fuel the Growth of the Veterinary Hospitals Segment
The end-user segment of the Animal Stem Cell Therapy industry is divided into Research Organizations and Veterinary Hospitals. In veterinary hospitals stem cell therapy offers the most promising and flexible option to restore function and improve animal health. Stem Cell Therapy is mainly used for treatment in canines, which is expected to fuel the growth of the veterinary hospital segment.
The product type segment of the Animal Stem Cell Therapy industry is classified into Horses, Dogs, and Others.
Regional Analysis
A Large Number of Pet Owners Offer Growth Potential for the U.S. Market
The region of North America is expected to grab a substantial share of the market due to high awareness regarding pet-care. The U.S. has a huge demand for Animal Stem Cell Therapy due to a large number of pet owners and increasing government support in animal healthcare, which is driving the growth of the Animal Stem Cell Therapy industry.
In the Asia-Pacific region, the increasing adoption of pet animals and the rising number of veterinary and day-to-day pet care institutions is likely to foster the growth of the market.
Get a Complete Market Report in your Inbox within 24 hours at https://www.qyrconsulting.com/request-sample/7937
Strategic Points Covered in TOC:
Chapter 1: Introduction, market driving force product scope, market risk, market overview, and market opportunities of the global Animal Stem Cell Therapy market
Chapter 2: Evaluating the leading manufacturers of the global Animal Stem Cell Therapy market which consists of its revenue, sales, and price of the products
Chapter 3: Displaying the competitive nature among key manufacturers, with market share, revenue, and sales
Chapter 4: Presenting global Animal Stem Cell Therapy market by regions, market share and with revenue and sales for the projected period
Chapter 5, 6, 7, 8 and 9: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions
About Us:
QYR Consulting established as a research firm in 2007 and has since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for a wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.
No comments:
Post a Comment